高度对代谢综合征的影响
Mahendra Prasad Bhatt1, Manavi Poudel2, Sushant Pokhrel3
1Department of Laboratory Medicine, Manmohan Memorial Institute of Health Sciences, Kathmandu, Nepal.
Journal of Nepal Health Research Council
|August 8, 2025
概括
高海拔地区的居民由于增加体力活动,代谢综合征的发病率较低. 促进健康的生活方式和定期进行健康检查可以帮助预防代谢综合征.
科学领域:
- 环境健康 环境健康
- 心血管健康 心血管健康
- 代谢障碍 代谢障碍 代谢障碍
背景情况:
- 代谢综合征涉及肥胖,高血压和脂质/碳水化合物代谢障碍.
- 高海拔地区的低氧和低压条件可能会影响能量代谢,影响脂质和葡萄糖.
- 评估尼泊尔高海拔和低海拔地区人口的代谢综合征患病率和风险因素至关重要.
研究的目的:
- 为了确定代谢综合征在尼泊尔高空和低海拔地区的流行率.
- 在这些不同的海拔群体中确定与代谢综合征相关的风险因素.
主要方法:
- 一项描述性的横截面研究,涉及116名参与者 (58名高海拔,58名低海拔) 在加德满都.
- 收集人体测量数据,血压和血液样本,用于分析禁食葡萄糖,脂质 (三糖,总胆固醇,高血压,低血压).
主要成果:
- 根据NCEP ATP III标准,代谢综合征的患病率在低海拔地区 (68.2%) 与高海拔地区 (31.8%) 的居民相比较高.
- 低HDL胆固醇,高甘油三,高禁食葡萄糖和高血压是代谢综合征的常见组成部分.
- 酒精消费,不健康的饮食和身体不活动被确定为代谢综合征的独立风险因素.
结论:
- 高山居民的代谢综合征患病率较低,可能与体力苛刻的工作和不那么久坐的生活方式有关.
- 鼓励健康的饮食习惯,积极的生活方式和定期的健康监测对于预防代谢综合征至关重要.
更多相关视频
相关概念视频
Overview of Carbohydrate Metabolism
1.8K
Carbohydrate metabolism is a fundamental biochemical process that ensures a constant supply of energy to living cells. The most important carbohydrate is glucose, which can be broken down via glycolysis to enter into the Krebs cycle and eventually lead to the production of ATP through oxidative phosphorylation.
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
Glucose transport into cells is facilitated by a family of transport proteins called GLUT (Glucose Transporters). GLUT4 is the primary glucose transporter for insulin-stimulated glucose...
1.8K
Factors Affecting Respiration
7.3K
Respiration is a crucial physiological function involving exchanging oxygen (O2) and carbon dioxide (CO2) between an organism and its environment. Various factors can impact this essential process:
7.3K
Overview of Lipid Metabolism
2.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
2.4K
Coronary Artery Disease I: Introduction
57
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
57
Cholesterol: Significance and Regulation
687
Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Considering cholesterol and...
687
Oral Hypoglycemic Agents: Biguanides and Glitazones
298
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
298


